Building off our previous study in nSR conditions (Ellinwood et al., 2017), we implemented an in silico assessment of IKur inhibitors in cAF atrial cardiomyocyte models, and identified metrics for delineating ideal KV1.5 blockers against AF. This evidence concerns the gene KCNA5 and atrial fibrillation.